Cash Flow Aceso Life Science Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-498.00
-4.00
-481.00
-611.00
-318.00
-486.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-107.00
566.00
346.00
92.00
-228.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-200.00
545.00
312.00
120.00
-338.00
-84.00
Cash Flow from Investing Activities
472.00
34.00
-480.00
-10.00
930.00
-1,152.00
Cash Flow from Financing Activities
-161.00
-141.00
301.00
-262.00
-307.00
824.00
Net Cash Inflow / Outflow
119.00
426.00
129.00
-140.00
283.00
-418.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
8.00
-12.00
-4.00
12.00
-1.00
-7.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Aceso Life Science Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-498.000000000293
-88.366
-410.00
-463.57%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-107.000000000063
17.374
-124.00
-715.86%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-200.000000000118
-2.616
-198.00
-7545.26%
Cash Flow from Investing Activities
472.000000000278
16.768
456.00
2714.89%
Cash Flow from Financing Activities
-161.000000000095
15.743
-176.00
-1122.68%
Net Cash Inflow / Outflow
119.00000000007
30.505
89.00
290.10%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
8.00000000000471
0.61
8.00
1211.48%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is -136.70% vs 74.68% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
-200.00
545.00
-136.70%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
